Jump to content
Knowledge Hub

News Archive

VICH - Reproduction: Studies to evaluate the safety of residues of veterinary drug in human food: reproduction studies

18th April 2024

Consultation end: 31JUL2024

Read More+

EMA - PRAC Meeting Highlights 8-11 April 2024

16th April 2024

Pharmacovigilance Risk Assessment Committee

Read More+

FDA - Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards

16th April 2024

Open for comments

Read More+

MHRA - DSUR Submissions and Fees are Changing

16th April 2024

From 1st June 2024

Read More+

NHS - AI and Digital Regulations Service (AIDRS)

15th April 2024

Building the AI and Digital Regulations Service

Read More+

EMA - EMA Management Board: highlights of March 2024 meeting

28th March 2024

Outcomes of the EMA Management Board meeting.

Read More+

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

28th March 2024

18-21 March 2024

Read More+

EMA - adjusted fees for applications to EMA from 1 April 2024

28th March 2024

The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on 1 April 2024.

Read More+

FDA - Guidance Documents for Consultation

28th March 2024

Guidance Documents open for public consultation.

Read More+

FDA Roundup, 26th March 2024

28th March 2024

An at-a-glance summary of news from around the agency:

Read More+
« Previous | Page 4 of 92 | Next »

Share

Virtual Event Platform